Related Experiment Videos
Multifocal synchronous osteosarcoma: the Scottish Bone Tumour Registry experience
R D Jones1, R Reid, G Balakrishnan
1Department of Oncology, Beatson Oncology Centre, Glasgow, Scotland.
Medical and Pediatric Oncology
|January 1, 1993
Summary
Multifocal synchronous osteosarcoma is rare in children, representing 1% of cases. These patients presented with multiple bone lesions and had poor survival outcomes despite treatment.
Area of Science:
- Pediatric Oncology
- Skeletal Oncology
- Tumorigenesis
Background:
- Osteosarcoma is the most common primary malignant bone tumor in children and adolescents.
- Multifocal synchronous osteosarcoma is an extremely rare variant.
- Understanding its pathogenesis is crucial for improving outcomes.
Observation:
- Three pediatric cases of multifocal synchronous osteosarcoma were identified over 30 years (1% of osteosarcoma cases).
- Patients presented with multiple bone lesions and no initial pulmonary metastases.
- The median age at presentation was 10 years.
Findings:
- Treatment included palliative radiotherapy and combination chemotherapy with radiotherapy.
- Survival was poor across all cases, with a median survival of 7 months.
- The study highlights the aggressive nature and poor prognosis of this rare osteosarcoma subtype.
Implications:
- Further genetic studies are proposed to investigate the origin of multifocal synchronous osteosarcoma.
- The findings prompt discussion on multicentric versus metastatic origins of these tumors.
- This research may inform future diagnostic and therapeutic strategies for rare pediatric bone cancers.